Education<\/p>\n
2015: Ph.D. in Life and Biomolecular Sciences Advanced training courses and qualifications: I obtained a master degree in Pharmaceutical Chemistry and Technology at the University of Salerno (Italy) in 2009 by defending a thesis on the effect of Toll-like receptor 9 agonists in modulating immune responses in lung cancer. In 2010 I joined the laboratory of Prof. Cecilia Garlanda and Prof. Alberto Mantovani to study the inflammatory processes associated with cancer development and progression. In 2014, I was awarded a fellowship from the Italian Foundation for Cancer Research (FIRC-AIRC). In 2015 I obtained a Ph.D. in Immunology and Life Sciences from The Open University (Milton Keynes, UK) and Humanitas Clinical and Research Centre. During my doctoral studies, I uncovered the essential role of Pentraxin 3 and the Complement system in regulating tumor-promoting inflammation. Moreover, I studied the properties of Interleukin-1 receptor 8 in controlling NK cell activity and I described its role as an NK cell checkpoint receptor in both viral infections and anti-tumor immunity. Notably, these discoveries were recognized by the ACTERIA-EFIS award as the best Ph.D. thesis in Immunology in Europe (2015-2018). In 2016 I joined the group led by Dr. Santiago Zelenay at the Cancer Research UK Manchester Institute, where I was awarded an EMBO long-term fellowship in 2016 and an EMBO advanced fellowship in 2019 to investigate the mechanisms of immune evasion in cancer driven by cyclooxygenase 2\/prostaglandin E2 axis, in a project with extensive translational potential. After more than 6 years in the UK, in 2022, thanks to the AIRC start-up program, I joined the IRCCS Humanitas Research Hospital to lead the Cellular and Molecular Oncoimmunology Lab. My group focuses on understanding the instructive mechanisms of immune escape in cancer with the aim of designing new therapeutic strategies for patients.<\/p>\n Academic honors, awards and prices<\/p>\n 2021<\/strong>: AIRC Start-up Grant 2021 (1 million \u20ac for 5 years) awarded by AIRC 2019<\/strong>: \u201cKeystone Symposia Future of Science Fund scholarship\u201d travel award to attend the Keystone meeting on \u201cInnate and Non-Classical Immune Cells in Cancer Immunotherapy\u201d, Keystone, Colorado. 2016<\/strong>: Award \u201cPremio Marzia Galli Kienle\u201d – SOS Foundation (Fondazione Solidarieta\u2019 in Oncologia San Marco- Zingonia) 2015<\/strong>: Award for best oral presentation at Word Immune Regulation Meeting 2015. Davos, Switzerland 2014<\/strong>: Award for best oral presentation at the Ph.D. student retreat of the Italian Society of Immunology and Allergology. Bari, Italy<\/p>\n <\/p>\n","protected":false},"featured_media":25755,"template":"","departament":[1237],"role":[1227],"yoast_head":"\n
\n<\/strong>The Open University, Milton Keynes UK; Affiliated Research Centre Humanitas Clinical and Research Center, Rozzano (Milan) ITALY
\n2009: Degree and Master in Pharmaceutical Chemistry and Technology
\n<\/strong>University of Salerno, Fisciano, ITALY.<\/p>\n
\n<\/strong>2021<\/strong>: \u201cEMBO Laboratory Leadership\u201d held by European Molecular Biology Organization, Germany 2021<\/strong>: \u201cInformation Security and Data Protection\u201d held by The University of Manchester, UK
\n2019<\/strong>: \u201cResearch Integrity\u201d held by Epigeum-Oxford University Press, UK
\n2016<\/strong>: \u201cEssential Data Analysis Skills for Biologists\u201d held by The University of Cambridge, UK<\/p>\n
\n2020<\/strong>: British Association for Cancer Research travel award
\n2019<\/strong>: EMBO Advanced Fellowship (\u00a379.830 for 2 years) granted by European Molecular Biology Organization<\/p>\n
\n2018<\/strong>: Doctoral Prize in Immunology (150.000 \u20ac for 3 years) awarded by ACTERIA and EFIS; Prize for best doctoral thesis in Immunology 2015-2018
\n2017<\/strong>: Award \u201cYoung innovator-Italy 2017\u201d \u2013 MIT Technology Review Italy
\n2016<\/strong>: EMBO long-term Fellowship (\u00a361.048 for 2 years) granted by European Molecular Biology Organization<\/p>\n
\n2016<\/strong>: Award \u201cPremio Marisa Colbacchini\u201d – Carlo Erba Foundation and ASIS
\n2015<\/strong>: Award \u201cPrix Galien Italy 2015\u201d
\n2015<\/strong>: NIBIT travel award to attend the \u201cCancer: Inflammation and Immunity\u201d meeting. Finalborgo, Italy
\n2015<\/strong>: Award for best oral presentation \u201cBright Spark Award\u201d at the 4th European congress of immunology. Wien, Austria
\n2015<\/strong>: EFIS travel award to attend the 4th European congress of immunology. Wien, Austria
\n2015<\/strong>: Poster award \u201c8th International Conference on Complement Therapeutics\u201d. Chania, Greece
\n2015<\/strong>: Seahorse Travel award to attend the Cell Symposia \u201cCancer, Inflammation and Immunity\u201d Sitges, Spain<\/p>\n
\n2014<\/strong>: FIRC-Fellowship for Italy 2014 (75.000 \u20ac for 3 years) granted by the Italian Foundation for Cancer Research<\/p>\n